Eyelid Surgery in Thyroid Eye Disease.
Journal
Ophthalmic plastic and reconstructive surgery
ISSN: 1537-2677
Titre abrégé: Ophthalmic Plast Reconstr Surg
Pays: United States
ID NLM: 8508431
Informations de publication
Date de publication:
01 Dec 2023
01 Dec 2023
Historique:
medline:
7
12
2023
pubmed:
6
12
2023
entrez:
6
12
2023
Statut:
ppublish
Résumé
To review and summarize a comprehensive synopsis of surgery of the eyelid in thyroid eye disease (TED). A PubMed search for specific eyelid manifestations of TED was performed. Studies reporting surgical management of these were reviewed, along with the author's own experience. The most common eyelid manifestations of TED include eyelid retraction, blepharoptosis, entropion, and epiblepharon, with most of them requiring surgical intervention. The correction of eyelid retraction has received maximum attention, with several surgical techniques that have stood the test of time. Blepharoptosis in TED that requires surgical intervention is usually aponeurotic. Entropion and Epiblepharon are rare in TED, and may resolve spontaneously, or following orbital decompression. Retraction is the commonest eyelid manifestation of TED, with multiple surgical options available for its correction. Blepharoptosis, entropion, and epiblepharon are rare eyelid findings in TED, that may occasionally require surgical correction.
Identifiants
pubmed: 38054989
doi: 10.1097/IOP.0000000000002543
pii: 00002341-202312001-00011
doi:
Types de publication
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
S92-S104Informations de copyright
Copyright © 2023 The American Society of Ophthalmic Plastic and Reconstructive Surgery, Inc.
Déclaration de conflit d'intérêts
The authors have no financial or conflicts of interest to disclose.
Références
Collin JRO, Allen L, Castronuovo S. Congenital eyelid retraction. Br J Ophthalmol. 1990;74:542–544.
Spierer A, Bourla N. Primary congenital upper eyelid retraction in infants and children. Ophthalmic Plast Reconstr Surg. 2004;20:246–248.
Bartley GB. The differential diagnosis and classification of eyelid retraction. Ophthalmology. 1996;103:168–176.
Uddin JM, Davies PD. Treatment of upper eyelid retraction associated with thyroid eye disease with subconjunctival botulinum toxin injection. Ophthalmology. 2002;109:1183–1187.
Lee SJ, Rim TH, Jang SY, et al. Treatment of upper eyelid retraction related to thyroid-associated ophthalmopathy using subconjunctival triamcinolone injections. Graefes Arch Clin Exp Ophthalmol. 2013;251:261–270.
Kohn JC, Rootman DB, Liu W, et al. Hyaluronic acid gel injection for upper eyelid retraction in thyroid eye disease: functional and dynamic high-resolution ultrasound evaluation. Ophthal Plast Reconstr Surg. 2014;30:400–404.
Goldberg RA, Lee S, Jayasundera T, et al. Treatment of lower eyelid retraction by expansion of the lower eyelid with hyaluronic acid gel. Ophthal Plast Reconstr Surg. 2007;23:343–348.
Kazim M, Gold KG. A review of surgical techniques to correct upper eyelid retraction associated with thyroid eye disease. Curr Opin Ophthalmol. 2011;22:391–393.
Naik MN, Vasanthapuram VH, Joseph J, et al. Microbial keratitis in thyroid eye disease: clinical features, microbiological profile, and treatment outcome. Ophthalmic Plast Reconstr Surg. 2019;35:543–548.
Velasco e Cruz AA, Vagner de Oliveira M. The effect of Müllerectomy on Kocher sign. Ophthalmic Plast Reconstr Surg. 2001;17:309–15; discussion 315.
Ribeiro SF, Garcia DM, Leal V, et al. Graded Müllerectomy for correction of Graves’ upper eyelid retraction: effect on eyelid movements. Ophthalmic Plast Reconstr Surg. 2014;30:384–387.
Lowinger A, Gill HS, Phan I, et al. Histology of Müller muscle observed in quiescent Graves’ orbitopathy. Can J Ophthalmol. 2013;48:468–470.
George JL, Tercero ME, Angioï-Duprez K, et al. Risk of dry eye after Mullerectomy via the posterior conjunctival approach for thyroid-related upper eyelid retraction. Orbit. 2002;21:19–25.
Mancini R, Forouzan P, Keenum ZG, et al. Sutureless conjunctiva-sparing posterior ptosis repair surgery: a novel technique. Am J Ophthalmol. 2023;251:77–89.
Pinas D, O B De Keizer R, Wubbels RJ, et al. Results of surgical correction of upper eyelid retraction in Graves’ Orbitopathy. Acta Ophthalmol. 2021;99:e608–e613.
Guastella C, di Furia D, Torretta S, et al. Upper eyelid retraction in graves’ ophthalmopathy: our surgical experience on 153 cases of full-thickness anterior blepharotomy with Mullerectomy. Aesthetic Plast Surg. 2022;46:1713–1721.
Henderson JW. A surgical procedure for retraction of eyelids in endocrine exophthalmos (a moving picture). Trans Am Ophthalmol Soc. 1965;63:70–74.
Watanabe A, Shams PN, Katori N, et al. Turn-over orbital septal flap and levator recession for upper-eyelid retraction secondary to thyroid eye disease. Eye (Lond). 2013;27:1174–1179.
Schwarz GS, Spinelli HM. Correction of upper eyelid retraction using deep temporal fascia spacer grafts. Plast Reconstr Surg. 2008;122:765–774.
Elner VM, Hassan AS, Frueh BR. Graded full-thickness anterior blepharotomy for upper eyelid retraction. Trans Am Ophthalmol Soc. 2003;101:67–73; discussion 73.
Hintschich C, Haritoglou C. Full thickness eyelid transection (blepharotomy) for upper eyelid lengthening in lid retraction associated with Graves’ disease. Br J Ophthalmol. 2005;89:413–416.
Taban MR. Lower eyelid retraction surgery without internal spacer graft. Aesthet Surg J. 2017;37:133–136.
Norris JH, Ross JJ, O’Reilly P, et al. A review of combined orbital decompression and lower eyelid recession surgery for lower eyelid retraction in thyroid orbitopathy. Br J Ophthalmol. 2011;95:1664–1669.
Park E, Lewis K, Alghoul MS. Comparison of efficacy and complications among various spacer grafts in the treatment of lower eyelid retraction: a systematic review. Aesthet Surg J. 2017;37:743–754.
Pieroni Goncalves AC, Gupta S, Monteiro MLR, et al. Customized minimally invasive orbital decompression surgery improves lower eyelid retraction and contour in thyroid eye disease. Ophthalmic Plast Reconstr Surg. 2017;33:446–451.
Scruggs RT, Black EH. Thyroid eye disease with significant levator involvement and ptosis: a case report. Ophthalmic Plast Reconstr Surg. 2015;31:e153–e154.
Chen Y-L, Yeh J-H, Chiu H-C. Clinical features of myasthenia gravis patients with autoimmune thyroid disease in Taiwan. Acta Neurol Scand. 2013;127:170–174.
Naik MN, Vasanthapuram VH. Demographic and clinical profile of 1000 patients with thyroid eye disease presenting to a tertiary eye care institute in India. Int Ophthalmol. 2021;41:231–236.
Vasanthapuram VH, Naik MN. Blepharoptosis in thyroid eye disease: etiopathogenesis, clinical features and correlation with thyroid eye disease. Int Ophthalmol. 2022;42:13–18.
Chung HW, Lee H, Baek S. Absent Bell’s phenomenon in patients with thyroid eye disease. BMC Ophthalmol. 2021;21:361.
Brogan K, Farrugia ME, Crofts K. Ptosis surgery in patients with Myasthenia Gravis: a useful adjunct to medical therapy. Semin Ophthalmol. 2018;33:429–434.
Saonanon P, Potita P. Contralateral Mueller’s muscle-conjunctiva resection: a therapeutic option in thyroid eye disease patients with unilateral eyelid retraction. Orbit. 2020;39:98–101.
Zloto O, Kapelushnik N, Sharon T, et al. The effect of upper eyelid muller muscle conjunctival resection surgery on lower eyelid position. Curr Eye Res. 2021;46:949–953.
Sajja K, Putterman AM. Müller’s muscle conjunctival resection ptosis repair in the aesthetic patient. Saudi J Ophthalmol. 2011;25:51–60.
Vasanthapuram VH, Naik MN. Lower eyelid entropion in thyroid eye disease. Orbit. 2022;41:335–340.
Goldberg RA, Christenbury JD, Shorr N. Medial entropion following orbital decompression for dysthyroid ophthalmopathy. Ophthalmic Plast Reconstr Surg. 1988;4:81–85.
Waller RR. Eyelid malpositions in Graves’ ophthalmopathy. Trans Am Ophthalmol Soc. 1982;80:855–930.
Mo F, Xu D, Xu H, et al. Shallow periorbital injection of triamcinolone acetonide in treatment of lower eyelid entropion related to thyroid-associated ophthalmopathy: three case reports. Medicine (Baltim). 2020;99:e19026.
Zhao J, Hodgson NM, Chang JR, et al. Thyroid eye disease-related epiblepharon: a comparative case study. Asia Pac J Ophthalmol (Phila). 2020;9:44–47.
Park SW, Khwarg SI, Kim N, et al. Acquired lower eyelid epiblepharon in thyroid-associated ophthalmopathy of Koreans. Ophthalmology. 2012;119:390–395.
Chang EL, Hayes J, Hatton M, et al. Acquired lower eyelid epiblepharon in patients with thyroid eye disease. Ophthalmic Plast Reconstr Surg. 2005;21:192–196.
Park SW, Kim N, Choung HK, et al. Outcomes of various surgical procedures on acquired lower eyelid epiblepharon in thyroid associated ophthalmopathy. Korean J Ophthalmol. 2012;26:319–323.
Sundar G, Young SM, Tara S, et al. Epiblepharon in East Asian patients: the Singapore experience. Ophthalmology. 2010;117:184–189.